MHRA authorises GSK’s Omjjara for treating symptoms in adult myelofibrosis with anaemia January 31, 2024 AutoBot News 0 GSK plcâs small molecule Omjjara (momelotinib), was granted marketing authorization (MA) yesterday (January 31) by the Medicines and Healthcare products Regulatory Agency (MHRA).